Darwin Global Management, Ltd.
Source: SEC Form 13F · as of Mar 2026Darwin Global Management, Ltd. holds 5 biotech & pharma companies tracked by BioSniper, totaling $3.31B in value as of Mar 2026 (SEC Form 13F).
Companies held
5
Total value held
$3.31B
BioSniper AIPage evidence connected
Prepared research question
What matters most for INSMED Inc (INSM)—catalysts, financial risk and supporting evidence?
Run cited research
Traceable citations · Unknowns marked
| Company | Shares | Value |
|---|---|---|
| INSMINSMED Inc | 16,805,184 | $2.58B |
| ABVXAbivax SA | 3,468,657 | $352.1M |
| RVMDREVOLUTION MEDICINES, INC. | 2,211,018 | $205.0M |
| ROIVRoivant Sciences Ltd. | 6,797,300 | $179.5M |
| DNTHDianthus Therapeutics, Inc. /DE/ | 17,357 | $1.5M |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.